Forvard P/S multiplikatori: MannKind Corp. (MNKD)

Ommaviy kompaniya MannKind Corp. (MNKD) logotipi

MannKind Corporation (MNKD) daromadlari Tyvaso DPI dan olingan royalti to'lovlari va Afrezza sotuvlariga asoslangan. GURU.Markets platformasi kelajakdagi P/S metrikasini efirga uzatadi, bunda 3.20 ko'rsatkichi parametr holatini belgilaydi. Steril zonalardagi robotlashtirilgan qadoqlash liniyalari kompaniyaning o'sishini ta'minlamoqda. Innovatsion kukun shaklidagi insulin bemorlar uchun inyeksiyalarni bartaraf etib, inqilobiy o'pka orqali dori yetkazib berish tizimini taklif etadi.

MNKD MannKind: Kapitalizatsiyaning prognoz qilingan daromadga nisbati 04.07.2022 - 15.11.2026 oraligʻida

MannKind Corporation (MNKD) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:MNKD (MannKind Corporation)
Afrezza original mahsuloti

MannKind Corporation an'anaviy inyeksiyalarni almashtirish orqali inhalatsiya yo'li bilan dori yetkazib berish tizimlari bozorini kengaytirmoqda. Forward P/S koeffitsiyenti biznesning bozor qiymatini kutilayotgan kelajakdagi sotuvlar bilan bog'lab, potentsial daromad o'sishi uchun qo'shimcha qiymatni o'lchaydi. Ushbu metrika likvidlik oqimlari sharoitida innovatsiyalar qanchalik samarali kapitalizatsiya qilinayotganini baholash imkonini beradi. Bashorat qilingan P/S tendentsiyasini tahlil qilish orqali investor aktivlarning haddan tashqari qimmat baholanishi xavfini o'z vaqtida aniqlashi mumkin.

MannKind Corporation raqobatchilari tahlili

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Amphastar (AMPH)|PCRX: Forvard narx/daromad multiplikatori|SPRY - Forvard P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning prognoz qilingan daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning prognoz qilingan daromadga nisbati|SCPH (scpharmaceuticals.com) - Forvard P/S multiplikatori|TECX: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Sotuvga nisbatan forvard narx BHST|Invizyne Technologies - Forvard P/S multiplikatori|oramed.com (ORMP) - Forvard narx/daromad multiplikatori|ENTX (enterabio.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HYFT|ABVC (ABVC BioPharma, Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori cumberlandpharma.com|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP